Latest Breaking News On - Luteinizing hormone - Page 9 : comparemela.com

Share this article Share this article ALBANY, N.Y., Jan. 18, 2021 /PRNewswire/ Diseases of endocrine system involving hormones are fairly extensive, and the endocrine testing market has been making continuous strides. The advances have been in relation to the accuracy of the assays and the growing awareness about the common symptoms of the disorders in global populations. Some of the most common ones are male and female infertility, hypothyroidism, and hyperthyroidism. Some of the key tests in demand are follicle stimulating hormone (FSH), Luteinizing Hormone (LH), estradiol, insulin, and thyroid-stimulating hormone (thyrotropin) (TSH). The worldwide prevalence of thyroid disorders has spurred the demand for endocrine testing for TSH levels. Advances in medical care and health infrastructure will propel the endocrine testing market to clock CAGR of 6.4% from 2019 to 2027. The revenue is expected to climb to reach US$ 10.6 Bn by the period-end.

United statesRohit bhiseyAsia pacificRoche ltdTransparency market researchAbbott laboratoriesBeckman coulter incLuteinizing hormoneEndocrine testing marketEndocrine testingEndocrine testing market reportTesting marketKey driving factorsF hoffmann la roche ltdBio rad laboratoriesThermo fisher